The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Shames Richard S. since year 2005.
The trader's CIK number is 1675878.
At the time of this reporting, Shames Richard S. is the Chief Medical Officer of Protagonist Therapeutics, Inc .
(stock ticker symbol PTGX).
See this page for all insider trading activities at Protagonist Therapeutics, Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-12-22||PTGX||Protagonist Therapeutics, Inc||Sale||3,529||20.50||72,344|
|2017-12-22||PTGX||Protagonist Therapeutics, Inc||Option Ex||3,529||4.21||14,857|
|2017-10-05||PTGX||Protagonist Therapeutics, Inc||Sale||2,017||19.00||38,323|
|2017-10-05||PTGX||Protagonist Therapeutics, Inc||Option Ex||2,017||4.21||8,491|
|2017-09-12||PTGX||Protagonist Therapeutics, Inc||Sale||3,687||14.31||52,753|
|2017-08-29||PTGX||Protagonist Therapeutics, Inc||Sale||1,512||17.00||25,704|
|2017-08-29||PTGX||Protagonist Therapeutics, Inc||Option Ex||1,512||4.21||6,365|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shames Richard S. (Chief Medical Officer of Protagonist Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.